Condition
Ischemic Cerebral Infarction
Total Trials
4
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
75%
3 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 3 (2)
P 4 (1)
Trial Status
Not Yet Recruiting3
Unknown1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07556887Not ApplicableNot Yet Recruiting
Clinical Impact of Using IMPROVE to Select Patients for Carotid Revascularisation
NCT07242599Phase 3Not Yet RecruitingPrimary
Ongericimab Injection Reducing Recurrence of Ischemic Stroke
NCT07121088Phase 4Not Yet RecruitingPrimary
Traditional Chinese Medicine Intervention for Ischemic Cerebrovascular Disease and Diabetes Mellitus: An Efficacy Comparative Study
NCT04205578Phase 3Unknown
NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events
Showing all 4 trials